Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More
Novo Nordisk Inc. can't preliminarily block allegedly deceptive ads by Eli Lilly & Co. comparing the rivals' GLP-1 medicines, a New Jersey federal court decided....To view the full article, register now.
Already a subscriber? Click here to view full article